1. Home
  2. SGMO vs HGBL Comparison

SGMO vs HGBL Comparison

Compare SGMO & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMO
  • HGBL
  • Stock Information
  • Founded
  • SGMO 1995
  • HGBL 1937
  • Country
  • SGMO United States
  • HGBL United States
  • Employees
  • SGMO N/A
  • HGBL N/A
  • Industry
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • HGBL Business Services
  • Sector
  • SGMO Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • SGMO Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • SGMO 180.5M
  • HGBL 60.6M
  • IPO Year
  • SGMO 2000
  • HGBL N/A
  • Fundamental
  • Price
  • SGMO $0.94
  • HGBL $1.68
  • Analyst Decision
  • SGMO Buy
  • HGBL
  • Analyst Count
  • SGMO 4
  • HGBL 0
  • Target Price
  • SGMO $2.67
  • HGBL N/A
  • AVG Volume (30 Days)
  • SGMO 2.5M
  • HGBL 56.2K
  • Earning Date
  • SGMO 10-30-2024
  • HGBL 11-07-2024
  • Dividend Yield
  • SGMO N/A
  • HGBL N/A
  • EPS Growth
  • SGMO N/A
  • HGBL N/A
  • EPS
  • SGMO N/A
  • HGBL 0.30
  • Revenue
  • SGMO $12,277,000.00
  • HGBL $55,019,000.00
  • Revenue This Year
  • SGMO N/A
  • HGBL N/A
  • Revenue Next Year
  • SGMO $52.02
  • HGBL $20.19
  • P/E Ratio
  • SGMO N/A
  • HGBL $5.77
  • Revenue Growth
  • SGMO N/A
  • HGBL N/A
  • 52 Week Low
  • SGMO $0.29
  • HGBL $1.52
  • 52 Week High
  • SGMO $1.48
  • HGBL $3.53
  • Technical
  • Relative Strength Index (RSI)
  • SGMO 58.17
  • HGBL 48.71
  • Support Level
  • SGMO $0.77
  • HGBL $1.64
  • Resistance Level
  • SGMO $1.07
  • HGBL $1.72
  • Average True Range (ATR)
  • SGMO 0.07
  • HGBL 0.06
  • MACD
  • SGMO 0.01
  • HGBL 0.02
  • Stochastic Oscillator
  • SGMO 59.30
  • HGBL 63.05

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: